These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31498938)

  • 1. Activation of BDNF/TrkB/Akt pathway is associated with aggressiveness and unfavorable survival in oral squamous cell carcinoma.
    Moraes JK; Wagner VP; Fonseca FP; Amaral-Silva GKD; de Farias CB; Pilar EFS; Gregianin L; Roesler R; Vargas PA; Martins MD
    Oral Dis; 2019 Nov; 25(8):1925-1936. PubMed ID: 31498938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of VEGF, BDNF, TRKB expression in oral epithelial dysplasia, oral verrucous carcinoma and oral squamous cell carcinoma and their role as prognostic indicator.
    Priyadharshini KI; Balakrishnan S; Saranyan R; Nirmal M; Murugesan A; Yoithappra Bhunath TPR
    J Cancer Res Ther; 2024 Jul; 20(5):1376-1383. PubMed ID: 39412903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BDNF/TrkB/Akt Signaling Pathway Epithelial Odontogenic Tumors and Keratocyst: An Immunohistochemical Study Comparative With Dental Germs.
    Dornelles FML; Wagner VP; Fonseca FP; Ariotti C; Carrard VC; Vargas PA; Sánchez-Romero C; Beovide V; Bologna-Molina R; Martins MD
    Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):366-373. PubMed ID: 32941187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral squamous cell carcinoma-released brain-derived neurotrophic factor contributes to oral cancer pain by peripheral tropomyosin receptor kinase B activation.
    Grayson M; Arris D; Wu P; Merlo J; Ibrahim T; Fang-Mei C; Valenzuela V; Ganatra S; Ruparel S
    Pain; 2022 Mar; 163(3):496-507. PubMed ID: 34321412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma.
    Lee J; Jiffar T; Kupferman ME
    PLoS One; 2012; 7(1):e30246. PubMed ID: 22276165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncovering the role of brain-derived neurotrophic factor/tyrosine kinase receptor B signaling in head and neck malignancies.
    de Moraes JK; Wagner VP; Fonseca FP; Vargas PA; de Farias CB; Roesler R; Martins MD
    J Oral Pathol Med; 2018 Mar; 47(3):221-227. PubMed ID: 28650560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix.
    Moon A; Won KY; Lee JY; Kang I; Lee SK; Lee J
    Pathology; 2011 Aug; 43(5):453-8. PubMed ID: 21670725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
    Li Z; Jaboin J; Dennis PA; Thiele CJ
    Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma.
    Kupferman ME; Jiffar T; El-Naggar A; Yilmaz T; Zhou G; Xie T; Feng L; Wang J; Holsinger FC; Yu D; Myers JN
    Oncogene; 2010 Apr; 29(14):2047-59. PubMed ID: 20101235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer.
    Yuan Y; Ye HQ; Ren QC
    Oncol Rep; 2018 Aug; 40(2):621-634. PubMed ID: 29989647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.
    Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y
    Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of BDNF-TRKB Interactions on Schwann Cell-induced Oral Squamous Cell Carcinoma Dispersion
    Ein L; Mei C; Bracho O; Bas E; Monje P; Weed D; Sargi Z; Thomas G; Dinh C
    Anticancer Res; 2019 Nov; 39(11):5933-5942. PubMed ID: 31704818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of brain-derived neurotrophic factor and its receptor TrkB is associated with poor prognosis and a malignant phenotype in small cell lung cancer.
    Kimura S; Harada T; Ijichi K; Tanaka K; Liu R; Shibahara D; Kawano Y; Otsubo K; Yoneshima Y; Iwama E; Nakanishi Y; Okamoto I
    Lung Cancer; 2018 Jun; 120():98-107. PubMed ID: 29748024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer.
    Yuan Y; Ye HQ; Ren QC
    Int J Oncol; 2018 Feb; 52(2):461-472. PubMed ID: 29345295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tropomyosine receptor kinase B on the migration of human Schwann cell and dispersion of oral tongue squamous cell carcinoma in vitro.
    Ein L; Bracho O; Mei C; Patel J; Boyle T; Monje P; Fernandez-Valle C; Bas E; Thomas G; Weed D; Sargi Z; Dinh C
    Head Neck; 2019 Dec; 41(12):4069-4075. PubMed ID: 31497919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Akt/mTOR pathway is activated in verrucous carcinoma of the oral cavity.
    Chaisuparat R; Limpiwatana S; Kongpanitkul S; Yodsanga S; Jham BC
    J Oral Pathol Med; 2016 Sep; 45(8):581-5. PubMed ID: 26775690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of long noncoding antisense RNA brain-derived neurotrophic factor attenuates hypoxia/reoxygenation-induced nerve cell apoptosis through the BDNF-TrkB-PI3K/Akt signaling pathway.
    Zhong JB; Li X; Zhong SM; Liu JD; Chen CB; Wu XY
    Neuroreport; 2017 Sep; 28(14):910-916. PubMed ID: 28777258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells.
    Huang YT; Lai PC; Wu CC; Hsu SH; Cheng CC; Lan YF; Chiu TH
    Int J Oncol; 2010 Jun; 36(6):1469-76. PubMed ID: 20428771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
    Wang Q; Zhang X; Song X; Zhang L
    Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDNF mimetic compound LM22A-4 regulates cementoblast differentiation via the TrkB-ERK/Akt signaling cascade.
    Kajiya M; Takeshita K; Kittaka M; Matsuda S; Ouhara K; Takeda K; Takata T; Kitagawa M; Fujita T; Shiba H; Kurihara H
    Int Immunopharmacol; 2014 Apr; 19(2):245-52. PubMed ID: 24530412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.